Correction to: Inhibition of RANKL improves the skeletal phenotype of adenine-induced chronic kidney disease in mice
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMyeloproliferative Neoplasms: Diagnosis and Treatment · Cytokine Signaling Pathways and Interactions · Apelin-related biomedical research
This is a correction to: Corinne E Metzger, Mizuho Kittaka, Alec N LaPlant, Yasuyoshi Ueki, Matthew R Allen, Inhibition of RANKL improves the skeletal phenotype of adenine-induced chronic kidney disease in mice, JBMR Plus, Volume 8, Issue 2, February 2024, ziae004, https://doi.org/10.1093/jbmrpl/ziae004.
In the originally published version of this manuscript, there was an error in Figure 3, which showed a repetition of the male images in place of the female images. This error has been corrected.
The publisher apologises for the error.